Bringing parity to infertility, with Jean Duvall
During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.
Newsletters and Deep Dive digital magazine
During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.
An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.
Men in England with high-risk prostate cancer will soon be able to get treatment with a drug available in Scotland and Wales for almost three years.
An AI that screens for early cognitive impairment by sifting through routine clinical documents has shown its value in a real-world evaluation.
Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that.
Editor's Picks
Newsletters and Deep Dive
digital magazine